Wikidata

(Q84596967)

English

Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin produc

scientific article published on 27 July 2010

In more languages

Statements

title
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20661737
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20661737%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q84596967&oldid=2144495011"